Cure My Disease

Don't miss your cure!

 Log in / Sign up

New radiation approach aims to tame prostate cancer with fewer side effects

NCT ID NCT07552168

Recruiting now Disease control Sponsor: Cancer Trials Ireland Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tests a next-generation radiation therapy (SABR) for men with low to high-risk prostate cancer. The goal is to see if this advanced technique can control the cancer while reducing long-term side effects like urinary and bowel problems. About 136 participants will receive the treatment and be followed for up to 5 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE ADENOCARCINOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bon Secours - UPMC Hillman

    RECRUITING

    Cork, T12 DV56, Ireland

    Contact Phone: •••-•••-••••

    Contact

  • Northern Ireland Cancer Centre (NICC)

    NOT_YET_RECRUITING

    Belfast, Ulster, BT9 7AB, United Kingdom

    Contact Phone: •••-•••-••••

    Contact

  • St Luke's Centre for Radiation Oncology at Beaumont Hospital

    NOT_YET_RECRUITING

    Dublin, Leinster, D09 FT51, Ireland

    Contact

    Contact Phone: •••-•••-••••

  • UPMC Hillman Cancer Centre at Whitfield Hospital

    RECRUITING

    Waterford, Ireland

    Contact

    Contact Phone: •••-•••-••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.